Efficacy and safety of a standardized hyperbaric... (2022 study) Skip to main content
Retrospective Study Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2022

Efficacy and safety of a standardized hyperbaric oxygen therapy protocol for retinal artery occlusion.

Di Vincenzo H, Kauert A, Martiano D, Chiabo J, Di Vincenzo D, Sozonoff I, et al., Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2022

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers looked back at the records of 28 patients treated at one hospital with a set protocol of hyperbaric oxygen sessions after a blockage of an artery in the eye.

What They Found

In this retrospective study of 28 patients with retinal artery occlusion, mean best-corrected visual acuity improved from 1.5 logMAR at referral to 0.9 logMAR after hyperbaric oxygen therapy (p equal to 0.001). Patients had central or branch occlusion for less than seven days. Treatment was a 90-minute session at 2.5 ATA, given twice daily, seven days a week, for at least 15 days, with an extra week if no reperfusion was seen on Day 15. Fifty-seven percent of patients were treated more than 12 hours after their first symptoms. High blood pressure (p equal to 0.039) and low initial visual acuity (p equal to 0.005) were linked to a poor outlook.

What This Means for Canadian Patients

For people with a recent blockage of an eye artery, this study describes one hospital's experience with twice-daily sessions at 2.5 ATA, and vision measures were better after treatment. Because there was no comparison group reported in the abstract, it cannot show that the sessions caused the change. People with high blood pressure or very poor starting vision did worse, so these are points to raise with an eye specialist.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective study of only 28 patients from a single center with no comparison group described, so it cannot prove that hyperbaric oxygen caused the improvement.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Ocular / Retinal
Source Pubmed
PubMed ID 36446295
Year Published 2022
Journal Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
MeSH Terms Humans; Hyperbaric Oxygenation; Retrospective Studies; Retinal Artery Occlusion; Oxygen; Fluorescein Angiography

Cite This Study

Share

Find a Canadian Clinic Treating Ocular / Retinal

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology